Flow Cytometry Laboratory
流式细胞术实验室
基本信息
- 批准号:10626518
- 负责人:
- 金额:$ 3.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-04-25 至 2028-03-31
- 项目状态:未结题
- 来源:
- 关键词:Advisory CommitteesAntibodiesAwardBasic ScienceBiologicalBiological AssayBiometryBiotechnologyBusinessesCalibrationCancer CenterCancer Center Support GrantCanis familiarisCell SeparationCellsClinicalClinical ResearchCollaborationsColorCommunitiesComprehensive Cancer CenterComputer softwareComputersConsultationsCytometryDNADataData AnalysesData SetDedicationsDevelopmentEducationEducational workshopFacultyFamily suidaeFlow CytometryFlow Cytometry Shared ResourceFluorescenceFundingGenomicsGoalsGrantHumanImageImmunologyImmunotherapyInfrastructureInstitutionInstructionInterventionJournalsLabelLaboratoriesLasersLeadershipLocationMalignant Childhood NeoplasmMalignant NeoplasmsMalignant neoplasm of ovaryManufacturerMarketingMeasuresMedical ResearchMethodsMissionModernizationPediatric NeoplasmPeer ReviewPlayPopulationProductivityProtocols documentationPublicationsPublishingRNARadiation therapyRadionuclide therapyReagentReproducibilityResearchResearch PersonnelResearch Project GrantsResource SharingResourcesRodentRoleSamplingServicesSortingStrategic PlanningSurveysTechnical ExpertiseTrainingTraining and EducationTranslational ResearchUnited States National Institutes of HealthUniversitiesWisconsinanimal imagingassay developmentcellular imagingcomplex datacomputerized toolscostdata acquisitiondesignequipment acquisitionexperienceexperimental studyinformatics shared resourceinstrumentinstrumentationlaboratory facilitylecturesmembernew technologynext generation sequencingoperationpediatric departmentpeerprecision medicineprogramsprotocol developmentradioactivity analysissatisfactionsingle cell analysissingle cell sequencingtheranostics
项目摘要
PROJECT SUMMARY / ABSTRACT
Since its inception in 1988, the Flow Cytometry Laboratory (FLOW) has served as the only comprehensive
shared resource on the UW-Madison campus for multiparameter flow cytometry, cell sorting and imaging cell
cytometry. The mission of FLOW is to operate a cutting-edge facility that provides UWCCC researchers the
infrastructure, technical expertise, and educational support required for fluorescence-based single cell analysis
and isolation that advances basic, translational, and clinical research. FLOW manages one 67-parameter Cytek
Aurora, five 16-parameter ThermoFisher Attune, one 20-parameter BD LSRII, and one 20-parameter BD LSR
Fortessa analytical cytometers; three BD FACSAria and one Sony MA900 cell sorters; and a Luminex
ImageStreamX MarkII imaging cytometer. Strong institutional support and funds from NIH S10 Shared
Instrumentation Grants have allowed FLOW to purchase and maintain state-of-the-art instruments, computers,
and software needed for data acquisition and analysis. FLOW operates facilities at two locations: 1) our main
laboratory in the Wisconsin Institute for Medical Research (WIMR), which is located on West Campus and
houses the majority of UWCCC researchers; and 2) a satellite facility in the UW Biotechnology Center (UWBC),
which is located on Central Campus near our remaining members and contiguous to facilities that provide DNA,
RNA, and single-cell next-generation sequencing to characterize freshly sorted single cells and cell populations.
FLOW partners with the Department of Pediatrics and the UWCCC Small Animal Imaging and Radiotherapy
Facility (SAIRF) to operate cytometers dedicated primarily to studies of pediatric cancers and analysis of
radioactive samples, respectively. The latter partnership was established to support targeted radionuclide
therapy of pediatric tumors in combination with immunotherapy. Dr. Manish Patankar (TM), a UWCCC member
and ovarian cancer researcher, serves as faculty leader. Ms. Dagna Sheerar has managed day-to-day
operations since 2011. Ms. Sheerar and her 6 staff members possess over 80 years of collective experience in
cytometry. The specific aims for FLOW are to: 1) evaluate new technologies and develop business plans to
procure and maintain new instruments allowing users access to cutting-edge approaches to single cell analytics
and sorting; 2) provide expert consultation and education services for single cell analytics and cell sorting ; and
3) organize user groups and develop data analysis support in collaboration with the Cancer Informatics Shared
Resource for the increasingly complex data sets generated by multi-parameter cytometers and sorters. During
the current CCSG funding cycle, FLOW served 109 unique UWCCC program members across all six programs
who collectively hold/held 445 cancer relevant research grants, including 118 awards from the NCI, and
contributed to 169 cancer relevant UWCCC member publications. Survey data indicate a high level of user
satisfaction and project increasing demand for services offered by FLOW.
项目概要/摘要
自 1988 年成立以来,流式细胞术实验室 (FLOW) 一直是唯一的综合性实验室
威斯康辛大学麦迪逊分校校园的多参数流式细胞术、细胞分选和细胞成像共享资源
细胞计数术。 FLOW 的使命是运营一个尖端设施,为 UWCCC 研究人员提供
基于荧光的单细胞分析所需的基础设施、技术专业知识和教育支持
和隔离促进基础、转化和临床研究。 FLOW 管理一台 67 参数 Cytek
Aurora、5 个 16 参数 ThermoFisher Attune、1 个 20 参数 BD LSRII 和 1 个 20 参数 BD LSR
Fortessa 分析细胞仪;三台 BD FACSAria 和一台 Sony MA900 细胞分选仪;和一个 Luminex
ImageStreamX MarkII 成像细胞仪。来自 NIH S10 的强大机构支持和资金共享
仪器补助金允许福禄购买和维护最先进的仪器、计算机、
以及数据采集和分析所需的软件。 FLOW 在两个地点运营设施:1) 我们的主要
威斯康星医学研究所 (WIMR) 的实验室位于西校区
UWCCC 的大部分研究人员都住在这里; 2) 威斯康星大学生物技术中心 (UWBC) 的卫星设施,
它位于中央校区,靠近我们剩余的成员,并且毗邻提供 DNA 的设施,
RNA 和单细胞下一代测序可表征新分选的单细胞和细胞群。
FLOW 与儿科和 UWCCC 小动物成像和放射治疗部合作
操作细胞仪的设施(SAIRF)主要用于儿科癌症的研究和分析
分别为放射性样品。后一个伙伴关系的建立是为了支持目标放射性核素
与免疫疗法相结合的儿童肿瘤治疗。 Manish Patankar 博士 (TM),UWCCC 会员
和卵巢癌研究员,担任教员领导。 Dagna Sheerar 女士负责管理日常事务
自 2011 年开始运营。Sheerar 女士和她的 6 名员工在以下方面拥有 80 多年的集体经验
细胞计数术。 FLOW 的具体目标是: 1) 评估新技术并制定业务计划
采购和维护新仪器,使用户能够获得单细胞分析的尖端方法
和排序; 2) 提供单细胞分析和细胞分选方面的专家咨询和教育服务;和
3)与癌症信息学共享组织合作组织用户组并开发数据分析支持
多参数细胞仪和分选仪生成的日益复杂的数据集的资源。期间
在当前的 CCSG 资助周期中,FLOW 为所有六个项目中的 109 名独特的 UWCCC 项目成员提供了服务
他们总共拥有 445 项癌症相关研究资助,其中包括 118 项来自 NCI 的奖项,以及
为 169 篇癌症相关的 UWCCC 成员出版物做出了贡献。调查数据显示用户水平较高
满意度并预计对福禄提供的服务的需求不断增加。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Manish S Patankar其他文献
Manish S Patankar的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Manish S Patankar', 18)}}的其他基金
Using a chemical biology approach to develop novel inhibitors of mitochondrial oxidative phosphorylation for the treatment of ovarian cancer
使用化学生物学方法开发用于治疗卵巢癌的新型线粒体氧化磷酸化抑制剂
- 批准号:
10260915 - 财政年份:2022
- 资助金额:
$ 3.94万 - 项目类别:
Using a chemical biology approach to develop novel inhibitors of mitochondrial oxidative phosphorylation for the treatment of ovarian cancer
使用化学生物学方法开发用于治疗卵巢癌的新型线粒体氧化磷酸化抑制剂
- 批准号:
10513296 - 财政年份:2022
- 资助金额:
$ 3.94万 - 项目类别:
Developing non-human primate models for ovarian cancer
开发卵巢癌的非人类灵长类动物模型
- 批准号:
10044729 - 财政年份:2020
- 资助金额:
$ 3.94万 - 项目类别:
Ovarian cancer diagnosis by monitoring immune cell bound MUC16 (CA125)
通过监测免疫细胞结合 MUC16 (CA125) 诊断卵巢癌
- 批准号:
8123435 - 财政年份:2010
- 资助金额:
$ 3.94万 - 项目类别:
相似国自然基金
新细胞因子FAM19A4联合CTLA-4抗体在肿瘤治疗的功能和机制研究
- 批准号:32370967
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于吡啶盐的可裂解抗体-药物偶联方法研究
- 批准号:22307081
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
人和小鼠中新冠病毒RBD的免疫原性表位及其互作抗体的表征和结构组学规律的比较研究
- 批准号:32371262
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于淬灭抗体的重金属镉快速定量免疫分析
- 批准号:22306074
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
TFAM条件性敲除重塑树突状细胞免疫代谢增强PD-1抗体抗肿瘤作用的机制研究
- 批准号:82303723
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Clonal hematopoiesis as a mediator of cardiovascular disease in women with premature menopause
克隆造血作为过早绝经女性心血管疾病的介质
- 批准号:
10570550 - 财政年份:2023
- 资助金额:
$ 3.94万 - 项目类别:
Bispecific Antibody Maintenance Therapy after Allogeneic Bone Marrow Transplant
同种异体骨髓移植后的双特异性抗体维持治疗
- 批准号:
10572777 - 财政年份:2023
- 资助金额:
$ 3.94万 - 项目类别:
Ultrasensitive, High-Specificity Rapid Test to Support the End-Game of the Global Program to Eliminate Lymphatic Filariasis
超灵敏、高特异性快速检测,支持全球消除淋巴丝虫病计划的最后阶段
- 批准号:
10480110 - 财政年份:2022
- 资助金额:
$ 3.94万 - 项目类别:
Trans-megakaryocyte migration as neutrophil amplifier
作为中性粒细胞放大器的跨巨核细胞迁移
- 批准号:
10449496 - 财政年份:2022
- 资助金额:
$ 3.94万 - 项目类别: